ductal carcinoma in situ | GenomeWeb

ductal carcinoma in situ

With more evidence for clinical utility in the scientific literature, the company expects finalized Medicare coverage before the end of the year.

The firm's revenues were hit by currency translation and differences in the timing of test reimbursement compared with the previous year's quarter.

In a large DCIS cohort, researchers showed the ability of Oncotype DX score to assess recurrence risk in patients treated with breast conservation surgery.

NEW YORK (GenomeWeb) ─ Genomic Health reported after the close of the market Tuesday that its third quarter revenues were up five percent year over year, falling slightly short of the Wall Street consensus estimate.

This article has been corrected to note that Brad Cole is Genomic Health's CFO and COO.

NEW YORK (GenomeWeb News) – Saying that Genomic Health's growth could fall short of consensus expectations, financial services firm Raymond James today downgraded shares of the Redwood City, Calif.-based firm's stock to Underperform from Market Perform.

NEW YORK (GenomeWeb News) – Genomic Health said after the close of the market on Friday that the national Medicare contractor for the firm's Oncotype DX breast cancer test has expanded Medicare coverage for the test.

In support of expanded utility for its Oncotype DX test in guiding cancer therapy decision-making, Genomic Health announced new data this week demonstrating that the test can help predict patients' risk of loco-regional recurrence after receiving chemotherapy and hormonal therapy


In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.